PubRank

Takayuki Yoshimoto

Author PubWeight™ 57.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Local expression of interleukin-27 ameliorates collagen-induced arthritis. Arthritis Rheum 2011 2.40
2 The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 2005 2.26
3 Potent antitumor activity of interleukin-27. Cancer Res 2004 1.80
4 An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J Immunol 2004 1.66
5 Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. Clin Dev Immunol 2010 1.59
6 Antiangiogenic and antitumor activities of IL-27. J Immunol 2006 1.50
7 Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J Immunol 2005 1.50
8 IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol 2007 1.50
9 Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res 2006 1.49
10 A role for IL-27 in early regulation of Th1 differentiation. J Immunol 2005 1.45
11 Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 2010 1.45
12 IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J Immunol 2006 1.34
13 IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. J Immunol 2007 1.24
14 Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1. Immunobiology 2006 1.23
15 Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses. J Immunol 2009 1.21
16 Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol 2013 1.20
17 Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett 2003 1.18
18 IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. J Immunol 2006 1.15
19 Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat Med 2008 1.09
20 Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthma. J Immunol 2012 1.08
21 Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J Virol 2004 1.06
22 TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Biochem Biophys Res Commun 2009 1.05
23 Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood 2007 1.05
24 Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity. Cancer Res 2009 1.02
25 STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production. J Immunol 2008 1.01
26 T-bet is required for protection against vaccinia virus infection. J Virol 2005 1.00
27 Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice. J Immunol 2007 0.98
28 No inhibition of IL-27 signaling by soluble gp130. Biochem Biophys Res Commun 2005 0.98
29 Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. Eur J Immunol 2011 0.93
30 A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes. J Biomed Biotechnol 2010 0.93
31 Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib. Cancer Sci 2013 0.93
32 Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation. J Bone Miner Metab 2007 0.91
33 Antimelanoma immunotherapy: clinical and preclinical applications of IL-12 family members. Immunotherapy 2010 0.90
34 IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner. PLoS One 2013 0.89
35 Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma. Mol Immunol 2009 0.87
36 Massive liver necrosis after provocation of imbalance between Th1 and Th2 immune reactions in osteopontin transgenic mice. J Gastroenterol 2004 0.86
37 Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT. Cancer Gene Ther 2004 0.86
38 IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3. Immunol Lett 2011 0.85
39 Antitumor activities of interleukin-27 on melanoma. Endocr Metab Immune Disord Drug Targets 2010 0.84
40 Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes. Viral Immunol 2006 0.83
41 Roles of CXC chemokines and macrophages in the recruitment of inflammatory cells and tumor rejection induced by Fas/Apo-1 (CD95) ligand-expressing tumor. Int J Cancer 2005 0.83
42 Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis. Biochem Biophys Res Commun 2004 0.82
43 Interleukin (IL)-17 versus IL-27: opposite effects on tumor necrosis factor-α-mediated chemokine production in human keratinocytes. Exp Dermatol 2011 0.81
44 Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen. Cancer Sci 2012 0.80
45 CD40 ligand rescues inhibitor of differentiation 3-mediated G1 arrest induced by anti-IgM in WEHI-231 B lymphoma cells. J Immunol 2004 0.78
46 Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells. Anticancer Res 2003 0.78
47 IL-27 promotes nitric oxide production induced by LPS through STAT1, NF-κB and MAPKs. Immunobiology 2012 0.78
48 Increased cytoprotective function in the liver of transgenic mice expressing osteopontin in hepatocytes. Hepatol Res 2005 0.78
49 Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice. Obes Res 2003 0.77
50 The ARNT-STAT3 axis regulates the differentiation of intestinal intraepithelial TCRαβ⁺CD8αα⁺ cells. Nat Commun 2013 0.77
51 Extrahepatic manifestations in transgenic mice of osteopontin in hepatocytes-A clue to advent of pathological state in various organs of chronic hepatitis C patients. Hepatol Res 2005 0.77
52 Efficient gene transfer to hepatoblastoma cells through asialoglycoprotein receptor and expression under the control of the cyclin A promoter. Biol Pharm Bull 2003 0.76
53 Molecular cloning and characterization of the mouse thymocyte protein gene. Gene 2002 0.76
54 Frequency and resistance of CD95 (Fas/Apo-1) gene-transfected tumor cells to CD95-mediated apoptosis by the elimination and methylation of integrated DNA. Int J Cancer 2006 0.76
55 Modulation of mThy28 nuclear protein expression during thymocyte development. Tissue Cell 2003 0.75
56 Modification of tumor cells with Fas (CD95) antigen gene and Fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer. Mol Biotechnol 2003 0.75
57 IL-23 gene therapy for mouse bladder tumour cell lines. BJU Int 2011 0.75
58 [From interleukin-19 (IL-19) to the latest cytokine IL-35]. Nihon Rinsho 2010 0.75